Pellagra: Difference between revisions

Line 2: Line 2:
Pellagra is the deficiency of Niacin (Vitamin B3).  Niacin deficiency classically causes the "4 D's": Dermatitis, Diarrhea, Dementia and Death."  Niacin is an important factor for the production of NADH and NADPH, which are important for redox reactions.  Deficiency therefore affects tissues with high turnover, including skin, GI tract and brain, thereby causing the "4 D's" mentioned above.
Pellagra is the deficiency of Niacin (Vitamin B3).  Niacin deficiency classically causes the "4 D's": Dermatitis, Diarrhea, Dementia and Death."  Niacin is an important factor for the production of NADH and NADPH, which are important for redox reactions.  Deficiency therefore affects tissues with high turnover, including skin, GI tract and brain, thereby causing the "4 D's" mentioned above.


Niacin is either consumed in the diet or converted from tryptophan by the hepatic kynurenine pathway in the liver.  Drugs that inhibit the production of niacin via this pathway can also result in pellagra.  Such drugs include the following:
*Niacin is either consumed in the diet or converted from tryptophan by the hepatic kynurenine pathway in the liver.  Drugs that inhibit the production of niacin via this pathway can also result in pellagra.  Such drugs include the following:
**Azathioprine
**Azathioprine
**Chloramphenicol
**Chloramphenicol
Line 11: Line 11:
**Pyrazinamide
**Pyrazinamide


Conditions that decrease niacin absoprtion from the GI tract can also lead to pellagra and include the following:
*Conditions that decrease niacin absoprtion from the GI tract can also lead to pellagra and include the following:
**Colitis
**Colitis
**Celiac disease
**Celiac disease

Revision as of 12:19, 7 February 2016

Background

Pellagra is the deficiency of Niacin (Vitamin B3). Niacin deficiency classically causes the "4 D's": Dermatitis, Diarrhea, Dementia and Death." Niacin is an important factor for the production of NADH and NADPH, which are important for redox reactions. Deficiency therefore affects tissues with high turnover, including skin, GI tract and brain, thereby causing the "4 D's" mentioned above.

  • Niacin is either consumed in the diet or converted from tryptophan by the hepatic kynurenine pathway in the liver. Drugs that inhibit the production of niacin via this pathway can also result in pellagra. Such drugs include the following:
    • Azathioprine
    • Chloramphenicol
    • Ethionamide
    • 5-Fluorouracil
    • Isoniazid
    • 6mercaptopurine
    • Pyrazinamide
  • Conditions that decrease niacin absoprtion from the GI tract can also lead to pellagra and include the following:
    • Colitis
    • Celiac disease
    • Crohn's disease
    • Ulcerative colitis
    • Cirrhosis
    • Gastrectomy patients

Neurological symptoms can also be exacerbated by supplementation by other B vitiamins, particularly B1, B2, B6, and B12. Mechanism is unknown but may be secondary to the increased demand of NAD.

Clinical Features

  • Skin photosensitivity and rash. Erythematous and scaly. May be mistaken for sunburn.
    • secondary to UV damage and decreased repair
    • "Casal's Necklace." Reddish rash surrounding the neck, and on the hands and feet. This is a photosensitivity rash in the exposed areas of the neck. Originally described by Gaspar Casal in 1735.
  • GI symptoms
    • secondary to decreased cell turnover
  • Neurological symptoms
    • "Pellagra encephalopathy," depression, anxiety, altered mental status, hallucinations, delusions, affective disorders, cognitive dysfunction.
  • Niacin deficiency is often associated with chronic alcohol use secondary to nutritional deficiency and malabsorption.

Differential Diagnosis

Diagnosis

Management

Niacin supplementation.

Disposition

See Also

External Links

References

  1. Badaway, Abdulla. “Pellagra and Alcoholism: a biochemical perspective.” Alcohol and alcoholism 2014; vol 49, No 3, pages 238-250
  2. Lopez, Marta, et al. “Pellagra Encephalopathy in the context of alcoholism: review and case report.” Alcohol and alcoholism. Vol 49. No 1. pages 38-41. 2014.